Assignee
ASTEX PHARMACEUTICALS INC
US·7 granted patents·7 pending applications·27 citations·filing 2013–2022
Top patents by PatentIndex Score
14 records- 0194US9480698B2Oligonucleotide analogues incorporating 5-aza-cytosine thereinASTEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·8 cites·17 claims
- 0294US9358248B2Oligonucleotide analogues incorporating 5-aza-cytosine thereinASTEX PHARMACEUTICALS INC·Filed 2013·Granted Jun 7, 2016·8 cites·27 claims
- 0391US10456415B2Oligonucleotide analogues incorporating 5-aza-cytosine thereinASTEX PHARMACEUTICALS INC·Filed 2016·Granted Oct 29, 2019·3 cites·46 claims
- 0487US9913856B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·6 cites·14 claims
- 0580US10517886B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2018·Granted Dec 31, 2019·2 cites·12 claims
- 0679US10933079B2Oligonucleotide analogues incorporating 5-aza-cytosine thereinASTEX PHARMACEUTICALS INC·Filed 2019·Granted Mar 2, 2021·0 cites·15 claims
- 0777US2022000900A1Oligonucleotide Analogues Incorporating 5-Aza-Cytosine ThereinASTEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0875US11058705B2Drug formulationsASTEX PHARMACEUTICALS INC·Filed 2019·Granted Jul 13, 2021·0 cites·19 claims
- 0960US2025026710A1Process for preparing a benzoate salt of a 1-(3-aminopyrrolidine-1-carbonyl)-3,4-diphenylbenzene compoundASTEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1059US2024228438A1Solid forms of salts of 4-[5-[(3s)-3-aminopyrrolidine-1-carbonyl]-2-[2-fluoro-4-(2- hydroxy-2-ethylpropyl)phenyl]phenyl]-2-fluoro-benzonitrileASTEX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1149US2022144881A1Compounds and methods for manufacture of hypomethylating agentsASTEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1239US2017360791A1Pharmaceutical compositions for increasing the bioavailability of poorly soluble drugsASTEX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1339US2020009247A1Drug combinationsASTEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1437US2016015805A1Drug combinationsASTEX PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →